Clinical Digoxin Toxicity in the Aged in Association With Co‐Administered Verapamil
- 1 September 1986
- journal article
- case report
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 34 (9) , 659-662
- https://doi.org/10.1111/j.1532-5415.1986.tb04908.x
Abstract
Digoxin toxicity occurs more commonly in aged than younger individuals. Cardioactive drugs such as quinidine effect digoxin pharmacokinetics so as to increase the potential for digoxin toxicity. The calcium-channel antagonists have become extensively used for cardiac disorders and are often co-administered with digoxin. Despite documented calcium-channel antagonist interactions with digoxin, clinically significant digoxin toxicity associated with their concurrent use is apparently unusual. Two elderly patients receiving digoxin and verapamil simultaneously are presented to demonstrate the clinical importance and potential danger of the concomitant use of these drugs.Keywords
This publication has 18 references indexed in Scilit:
- Digoxin-diltiazem interactionThe American Journal of Cardiology, 1984
- The effect of nifedipine on serum digoxin concentrations in patientsAmerican Heart Journal, 1984
- The Influence of Calcium Antagonists on Plasma Digoxin ConcentrationActa Medica Scandinavica, 1984
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Verapamil and digoxin: Their respective effects on atrial fibrillation and their interactionThe American Journal of Cardiology, 1982
- The influence of quinidine and other agents on digitalis glycosidesAmerican Heart Journal, 1982
- Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation.Circulation, 1982
- The influence of verapamil on serum digoxin concentration.Circulation, 1982
- Quinidine-Digoxin InteractionNew England Journal of Medicine, 1979
- William Withering and the Purple FoxgloveScientific American, 1965